← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2010Last known activity
Sep 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT06494280OfficialN/ASep 30, 2024
- NCT06494280Lead sponsorN/ASep 30, 2024
- NCT06494280Sponsor investigatorN/ASep 30, 2024
- NCT06580327Lead sponsorN/ASep 25, 2024
- NCT06580327Sponsor investigatorN/ASep 25, 2024
- NCT06580327OfficialN/ASep 25, 2024
- NCT01094158CollaboratorPhase 2Nov 1, 2010
Details
- Last known activity
- Sep 30, 2024